Cyrcadia, Inc., a Reno company in that develops technology for breast cancer detection, has commenced a clinical trial for its wearable early detection of breast cancer device and is enrolling the first trial participants at El Camino Hospital in Mountain View, Calif. Utilizing its previous FDA cleared device as a predicate, Cyrcadia is combining its fourth generation, wearable device technology, made by Flextronics, and the Salesforce database software to track the clinical trial results.
Cyrcadia, Inc., was founded as First Warning Systems in 2008.
